-The Information
Biophytis Announces Receipt Of Nasdaq Notice The Company No Longer Satisfies Nasdaq Listing Rule 5550(a)(2)
Biophytis SA (NASDAQ:BPTS)(PARIS:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes